Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis
- 341 Downloads
Cytochrome P4501A1 (CYP1A1) enzyme is a member of the CYP superfamily of enzymes. CYP1A1 A2455G and T3801C are two most commonly studied polymorphisms loci. Previous studies have reported that CYP1A1 polymorphisms increase esophageal cancer (EC) risk. However, the results remain controversial and ambiguous. To further investigate the association between CYP1A1 polymorphisms (A2455G and T3801C) and EC risk. A meta-analysis was performed to investigate the association between CYP1A1 polymorphisms and EC risk. A total of 13 articles (A2455G and T3801C: 2 papers, A2455G: 8 papers, T3801C: 3 papers) from the PubMed containing information on the CYP1A1 polymorphisms and EC were included in this meta-analysis, with summational sample size of 1,881 EC cases and 3,786 controls. Stratified analysis was performed to evaluate the ethnicity (Caucasians and Asian) and histopathology type (esophageal squamous cell carcinoma and esophageal adenocarcinoma) effect. No obvious publication bias in the two polymorphisms was observed. Our meta-analysis revealed a significant association between the A2455G polymorphism and EC (OR = 1.55 per A allele, 95 % CI 1.29–1.85, P < 0.001). Stratification analysis by ethnicity and histopathology type showed significant association in the population of Asian origin (OR = 1.55, 95 % CI 1.28–1.89, P < 0.001) and in histopathology type of ESCC (OR = 1.40, 95 % CI 1.19–1.65, P < 0.001). We didn’t observe the significant association between CYP1A1 T3801C polymorphism and EC. We observed a difference of allele frequencies between Caucasian and Asian population in the meta-analysis. The allele frequencies in our meta-analysis were consistent with the allele frequencies in 1000 Genome Project. Our meta-analysis demonstrated distinct evidence that CYP1A1 A2455G polymorphism was associated with the risk of EC.
KeywordsCYP1A1 Esophageal cancer Polymorphism Meta-analysis
Dr. Hou-Feng Zheng is supported by the Canadian Institutes of Health Research (CIHR). We thank Dr. Wan-Cai Yang from the School of Basal Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China, for carefully reading of this manuscript.
Conflict of interest
- 24.Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G et al (2004) GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 10:3389–3393PubMedGoogle Scholar
- 33.Layke JC, Lopez PP (2006) Esophageal cancer: a review and update. Am Fam Phys 73:2187–2194Google Scholar
- 35.Umar SB, Fleischer DE (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5:517–526 Google Scholar